Artificial Intelligence

In what it's calling "one of the most ambitious initiatives in its 250-year history," NewYork-Presbyterian has launched a new $2 billion capital campaign that has advanced technologies and digital transformation as core goals. WHY IT MATTERS With its For Every Future initiative, NYP hopes to raise that sum by the end of 2028 as it aims to capitalize on a "pivotal moment in medicine, with artificial intelligence and new technologies pushing the boundaries of what's possible, from catching heart failure before it happens to detecting cancer earlier." Additionally, the big-ticket capital campaign will be targeted toward "transformative" new clinical spaces at the NewYork-Presbyterian/Columbia University Irving Medical Center, the health system says, and a "state-of-the-art" ambulatory space in nearby White Plains. The goal is to invest heavily in "talent and technology to bring the healthcare of the future to the present," according to NewYork-Presbyterian, with equity and health justice as lodestars, clinical leaders say. "NewYork-Presbyterian is a leader in health care that combines clinical talent and technology to improve patients' lives," said Dr. Deepa Kumaraiah, senior vice president and chief medical officer at NewYork-Presbyterian. "With outstanding teams committed to health equity, we continue to improve outcomes, enhance access and reduce health disparities." THE LARGER TREND The health system – which comprises 10 hospitals and some 200 primary and specialty care clinics across the metro region – has been a leader in IT-enabled care, such as with its community-focused telehealth and advanced virtual care services. Over the years, Healthcare IT News has offered many case studies and features exploring the health system's leading edge technology, from an AI command center to on-demand digital health services, and from AI-enabled analytics to combat the opioid crisis to centralized teletracking for data automation. ON THE RECORD "NewYork-Presbyterian is transforming the way health care is delivered, leveraging technology to put patients' needs first and expand access to exceptional care," said Dr. Steven J. Corwin, president and chief executive officer of NewYork-Presbyterian. "Every day, we are advancing research and treatments that will change lives and shape the future of medicine." "NewYork-Presbyterian is at the forefront of health care's future," said Jerry Speyer, cochair of NewYork-Presbyterian Hospital's Board of Trustees. "Our teams are using new technologies to advance how we prevent, diagnose, and treat disease. We bring that great care to all patients who come to us." Mike Miliard is executive editor of Healthcare IT News Email the writer: mike.miliard@himssmedia.com Healthcare IT News is a HIMSS publication.

AKASA cofounder and CEO Malinka Walaliyadde says automation has helped the revenue cycle company find a return of $1.5 million in recovered additional revenue per each $1 billion of total patient revenue.

Also:  New studies find commercial artificial intelligence algorithms developed for breast cancer detection may identify women at high risk of future malignancy – up to six years ahead of occurrence.

ORs are high-risk, high-cost environments where patient safety depends on the clinician’s ability to predict surgical risk. The Caresyntax surgical intelligence platform promises personalised interventions, tailored treatments and improved outcomes.

Healthcare operates with the understanding that no system is impenetrable, but must improve incident response practices by finding new ways to stay operational after network attacks, says one panelist at the upcoming HIMSS Cybersecurity Forum.

Its telehealth technology will use the Suki artificial intelligence platform to generate clinical notes to help reduce documentation burden.

E.mersion Studios CEO and creative director David Bolinsky describes how artificial intelligence helps him draw accurate representations of human anatomy – and discusses how image generators’ hallucinations affect scientific illustration.

HIMSS has shifted the focus from adoption to utilisation in the updated version of the Adoption Model for Analytics Maturity, says Chief Relationship Officer Mitch Icenhower.

In this executive brief, we explore how AWS's generative AI solutions can unlock transformative opportunities for your life sciences organization.

In today's rapidly evolving life sciences landscape, generative AI is emerging as a game-changing force, poised to drive unprecedented innovation and break through long-standing barriers. At Amazon Web Services (AWS), we understand the immense potential of this transformative technology and offer tailored solutions to help you harness its power.